lamtherapeutics.com
LAM Therapeutics Announces Close of $58M Series C Financing and New Clinical Program in Cancer
Return to News > Strategy and Portfolio Update GUILFORD, Conn., March 30, 2017 – LAM Therapeutics, a 4Catalyzer company that develops drugs for cancer and rare diseases, announced that it has closed $58M in Series C financing. 4Catalyzer is Connecticut’s premier biotechnology incubator and has raised over a quarter billion dollars to support its current class